Sangamo Therapeutics
SGMO
#10512
Rank
ยฃ15.68 M
Marketcap
ยฃ0.03785
Share price
0.00%
Change (1 day)
-90.38%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -ยฃ83.1 Million

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are ยฃ32.87 Million. In 2024 the company made an earning of -ยฃ74.53 Million, an increase over its 2023 earnings that were of -ยฃ90.08 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ83.1 Million11.5%
2024 -ยฃ74.53 Million-17.27%
2023 -ยฃ90.08 Million-40.88%
2022 -ยฃ0.16 Billion9.79%
2021 -ยฃ0.14 Billion41.52%
2020 -ยฃ98.07 Million23.17%
2019 -ยฃ79.63 Million36.33%
2018 -ยฃ58.41 Million36.89%
2017 -ยฃ42.67 Million-22.32%
2016 -ยฃ54.93 Million54.86%
2015 -ยฃ35.47 Million75.62%
2014 -ยฃ20.2 Million0.13%
2013 -ยฃ20.18 Million
2011 -ยฃ27.12 Million43.66%
2010 -ยฃ18.88 Million28.52%
2009 -ยฃ14.69 Million-23.55%
2008 -ยฃ19.22 Million2.45%
2007 -ยฃ18.76 Million19.5%
2006 -ยฃ15.7 Million50.78%
2005 -ยฃ10.41 Million75%
2004 -ยฃ5.95 Million-33.25%
2003 -ยฃ8.91 Million-62.27%
2002 -ยฃ23.62 Million102.82%
2001 -ยฃ11.65 Million23.21%
2000 -ยฃ9.45 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.66 B-23,928.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.87 B-8,434.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ1.22 B-1,588.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-ยฃ1.92 Billion 2,217.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ7.41 B-9,085.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ9.95 B-12,163.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ0.65 B-897.67%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.29 B-453.67%๐Ÿ‡บ๐Ÿ‡ธ USA